aTYR PHARMA INC (ATYR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $4k
- Feb 4 · No plan
- Form 4 sales
- 21
- On record
- Form 144 notices
- 0
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Feb 4, 2026No plan
Shukla Sanjay, President and CEO, sold 2.4% of their holdings
$4k3,745 shares at $0.98
- Feb 4, 2026No plan
Broadfoot Jill Marie, Chief Financial Officer, sold 4% of their holdings
$2k1,558 shares at $0.98
- Feb 4, 2026No plan
Denyes Nancy, General Counsel, sold 3.3% of their holdings
$1k1,118 shares at $0.98
- Feb 4, 2025No plan
Broadfoot Jill Marie, Chief Financial Officer, sold 3.8% of their holdings
$5k1,254 shares at $3.78
- Feb 4, 2025No plan
Denyes Nancy, General Counsel, sold 3.3% of their holdings
$3k899 shares at $3.78
- Feb 6, 2024No plan
Broadfoot Jill Marie, Chief Financial Officer, sold 7.1% of their holdings
$3k1,590 shares at $1.69
- Feb 6, 2023Plan not stated
Broadfoot Jill Marie, Chief Financial Officer, sold 9.2% of their holdings
$4k1,566 shares at $2.36
- May 21, 2021Plan not stated
Clarke John K, Director, sold 2.3% of their holdings
$11k2,500 shares at $4.34
- Feb 9, 2021Plan not stated
Broadfoot Jill Marie, Chief Financial Officer, sold 3.8% of their holdings
$3k390 shares at $7.66
- Feb 9, 2021Plan not stated
Shukla Sanjay, President and CEO, sold 8.6% of their holdings
$6k778 shares at $7.66
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 1, 2026 | ATYR | Yaras Brandon | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 410,000 | 410,000 | SEC | ||
| May 27, 2026 | May 28, 2026 | ATYR | Schimmel Paul | Director | Bought | 100,000 | $0.50 | $50k | 779,143 | SEC |
| May 11, 2026 | May 13, 2026 | ATYR | Lucas Svetlana | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 11, 2026 | May 13, 2026 | ATYR | Gross Jane A | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 11, 2026 | May 13, 2026 | ATYR | Benevich Eric | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 11, 2026 | May 13, 2026 | ATYR | Zaknoen Sara | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 11, 2026 | May 13, 2026 | ATYR | Coughlin Timothy | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 11, 2026 | May 13, 2026 | ATYR | Schimmel Paul | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Feb 4, 2026 | Feb 4, 2026 | ATYR | Shukla Sanjay | President and CEO | Sold | 3,745 | $0.98 | $4k | 153,553 | SEC |
| Feb 4, 2026 | Feb 4, 2026 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Sold | 1,558 | $0.98 | $2k | 37,296 | SEC |
| Feb 4, 2026 | Feb 4, 2026 | ATYR | Denyes Nancy | General Counsel | Sold | 1,118 | $0.98 | $1k | 33,124 | SEC |
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Shukla Sanjay | President and CEO | Exercised or settledRestricted Stock Unit | 10,375 | 0 | SEC | ||
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Shukla Sanjay | President and CEO | Exercised options | 10,375 | 157,298 | SEC | ||
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 3,750 | 0 | SEC | ||
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Exercised options | 3,750 | 38,854 | SEC | ||
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Denyes Nancy | General Counsel | Exercised or settledRestricted Stock Unit | 2,687 | 0 | SEC | ||
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Denyes Nancy | General Counsel | Exercised options | 2,687 | 34,242 | SEC | ||
| Jan 9, 2026 | Jan 9, 2026 | ATYR | Shukla Sanjay | President and CEO | AwardedEmployee Stock Option (right to buy) | 1.5M | 1.5M | SEC | ||
| Jan 9, 2026 | Jan 9, 2026 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 412,500 | 412,500 | SEC | ||
| Jan 9, 2026 | Jan 9, 2026 | ATYR | Denyes Nancy | General Counsel | AwardedEmployee Stock Options (right to buy) | 412,500 | 412,500 | SEC | ||
| Oct 9, 2025 | Oct 9, 2025 | ATYR | Schimmel Paul | Director | Bought | 1M | $0.91 | $913k | 1.4M | SEC |
| May 1, 2025 | May 2, 2025 | ATYR | Zaknoen Sara | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 1, 2025 | May 2, 2025 | ATYR | Schimmel Paul | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 1, 2025 | May 2, 2025 | ATYR | Lucas Svetlana | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 1, 2025 | May 2, 2025 | ATYR | Gross Jane A | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 1, 2025 | May 2, 2025 | ATYR | Benevich Eric | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 1, 2025 | May 2, 2025 | ATYR | Coughlin Timothy | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Mar 17, 2025 | Mar 17, 2025 | ATYR | Gross Jane A | Director | Bought | 3,750 | $4.00 | $15k | 9,750 | SEC |
| Feb 4, 2025 | Feb 4, 2025 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Sold | 1,254 | $3.78 | $5k | 31,763 | SEC |
| Feb 4, 2025 | Feb 4, 2025 | ATYR | Denyes Nancy | General Counsel | Sold | 899 | $3.78 | $3k | 26,555 | SEC |
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Shukla Sanjay | President and CEO | Exercised or settledRestricted Stock Unit | 10,375 | 10,375 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Shukla Sanjay | President and CEO | Exercised options | 10,375 | 146,923 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 3,750 | 3,750 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Exercised options | 3,750 | 33,017 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Denyes Nancy | General Counsel | Exercised or settledRestricted Stock Unit | 2,687 | 2,687 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Denyes Nancy | General Counsel | Exercised options | 2,687 | 27,454 | SEC | ||
| Jan 8, 2025 | Jan 10, 2025 | ATYR | Shukla Sanjay | President and CEO | AwardedEmployee Stock Option (right to buy) | 1M | 1M | SEC | ||
| Jan 8, 2025 | Jan 10, 2025 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 275,000 | 275,000 | SEC | ||
| Jan 8, 2025 | Jan 10, 2025 | ATYR | Denyes Nancy | General Counsel | AwardedEmployee Stock Option (right to buy) | 275,000 | 275,000 | SEC | ||
| Dec 10, 2024 | Dec 12, 2024 | ATYR | Benevich Eric | Director | AwardedStock Option (right to buy) | 100,000 | 100,000 | SEC | ||
| Jul 24, 2024 | Jul 24, 2024 | ATYR | Schimmel Paul | Director | Bought | 100,000 | $1.84 | $184k | 413,023 | SEC |
| Jun 5, 2024 | Jun 6, 2024 | ATYR | Denyes Nancy | General Counsel | Bought | 5,000 | $1.86 | $9k | 22,267 | SEC |
| May 31, 2024 | Jun 3, 2024 | ATYR | Broadfoot Jill Marie | Chief Financial Officer | Bought | 5,000 | $1.79 | $9k | 27,960 | SEC |
| May 31, 2024 | Jun 3, 2024 | ATYR | Shukla Sanjay | President and CEO | Bought | 20,000 | $1.81 | $36k | 136,548 | SEC |
| May 30, 2024 | Jun 3, 2024 | ATYR | Coughlin Timothy | Director | Bought | 50,000 | $1.75 | $88k | 56,000 | SEC |
| May 22, 2024 | May 23, 2024 | ATYR | Clarke John K | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC | ||
| May 22, 2024 | May 23, 2024 | ATYR | Gross Jane A | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC | ||
| May 22, 2024 | May 23, 2024 | ATYR | Lucas Svetlana | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC | ||
| May 22, 2024 | May 23, 2024 | ATYR | Schimmel Paul | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC | ||
| May 22, 2024 | May 23, 2024 | ATYR | Zaknoen Sara | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC |
Sales, notices and lockups (21)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Feb 4, 2026 | Shukla Sanjay | ATYR | President and CEO | Form 4 sale | 3,745 | $4k | 2.4% | No plan | SEC |
| Feb 4, 2026 | Feb 4, 2026 | Broadfoot Jill Marie | ATYR | Chief Financial Officer | Form 4 sale | 1,558 | $2k | 4.0% | No plan | SEC |
| Feb 4, 2026 | Feb 4, 2026 | Denyes Nancy | ATYR | General Counsel | Form 4 sale | 1,118 | $1k | 3.3% | No plan | SEC |
| Feb 4, 2025 | Feb 4, 2025 | Broadfoot Jill Marie | ATYR | Chief Financial Officer | Form 4 sale | 1,254 | $5k | 3.8% | No plan | SEC |
| Feb 4, 2025 | Feb 4, 2025 | Denyes Nancy | ATYR | General Counsel | Form 4 sale | 899 | $3k | 3.3% | No plan | SEC |
| Feb 6, 2024 | Feb 6, 2024 | Broadfoot Jill Marie | ATYR | Chief Financial Officer | Form 4 sale | 1,590 | $3k | 7.1% | No plan | SEC |
| Feb 6, 2023 | Feb 6, 2023 | Broadfoot Jill Marie | ATYR | Chief Financial Officer | Form 4 sale | 1,566 | $4k | 9.2% | Plan not stated | SEC |
| May 21, 2021 | May 25, 2021 | Clarke John K | ATYR | Director | Form 4 sale | 2,500 | $11k | 2.3% | Plan not stated | SEC |
| Feb 9, 2021 | Feb 9, 2021 | Broadfoot Jill Marie | ATYR | Chief Financial Officer | Form 4 sale | 390 | $3k | 3.8% | Plan not stated | SEC |
| Feb 9, 2021 | Feb 9, 2021 | Shukla Sanjay | ATYR | President and CEO | Form 4 sale | 778 | $6k | 8.6% | Plan not stated | SEC |
| Sep 2, 2020 | Sep 3, 2020 | Clarke John K | ATYR | Director | Form 4 sale | 7,360 | $30k | 6.2% | Plan not stated | SEC |
| Aug 27, 2020 | Aug 28, 2020 | Clarke John K | ATYR | Director | Form 4 sale | 7,640 | $32k | 6.1% | Plan not stated | SEC |
| May 20, 2020 | May 28, 2020 | Denyes Nancy | ATYR | General Counsel | Form 4 sale | 322 | $1k | 10.5% | Plan not stated | SEC |
| May 20, 2020 | May 22, 2020 | Schimmel Paul | ATYR | Director | Form 4 sale | 8,447 | $31k | 1.9% | Plan not stated | SEC |
| Feb 7, 2020 | Feb 7, 2020 | Shukla Sanjay | ATYR | President and CEO | Form 4 sale | 745 | $3k | 36.6% | Unusual | SEC |
| Feb 7, 2020 | Feb 7, 2020 | Broadfoot Jill Marie | ATYR | Chief Financial Officer | Form 4 sale | 375 | $2k | 5.0% | Plan not stated | SEC |
| May 17, 2019 | May 20, 2019 | Krueger Nancy | ATYR | General Counsel | Form 4 sale | 4,651 | $2k | 15.5% | Plan not stated | SEC |
| May 16, 2018 | May 16, 2018 | EcoR1 Capital Fund Qualified, L.P. | ATYR | 10% owner | Form 4 sale | 3.2M | $3M | 100.0% | Unusual | SEC |
| Feb 8, 2018 | Feb 8, 2018 | Blake John T | ATYR | Senior Vice President, Finance | Form 4 sale | 1,402 | $5k | 42.1% | Unusual | SEC |
| Feb 8, 2018 | Feb 8, 2018 | Amanullah Ashraf | ATYR | Officer | Form 4 sale | 1,402 | $5k | 42.1% | Unusual | SEC |
| Nov 13, 2017 | Dec 14, 2017 | EcoR1 Capital Fund Qualified, L.P. | ATYR | 10% owner | Form 4 sale | 13,832 | $56k | 0.4% | Plan not stated | SEC |